Stakeholders' views of alternatives to prospective informed consent for minimal-risk pragmatic comparative effectiveness trials

Journal of Law, Medicine and Ethics

Volumn 43, Issue 2, 2015, Pages 397-409

  Whicher, Danielle ^a   Kass, Nancy ^b,c   Faden, Ruth ^b  

^a Outcomes Research Institute   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COMPARATIVE EFFECTIVENESS; FEMALE; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; PROFESSIONAL STANDARD; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; UNITED STATES;

ADULT; COMPARATIVE EFFECTIVENESS RESEARCH; DISCLOSURE; ETHICS COMMITTEES, RESEARCH; FEMALE; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; PRAGMATIC CLINICAL TRIALS AS TOPIC; UNITED STATES;

EID: 84939195231     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/jlme.12256     Document Type: Article

References (29)

1. S. R. Tunis et al., "Comparative Effectiveness Research: Policy Context, Methods Development and Research Infrastructure, "Statistics in Medicine 29, no. 19 (2010): 1963-1976.
2. Institute of Medicine, Initial National Priorities for Comparative Effectiveness Research (Washington, D.C.: National Academies Press, June 2009).
3. American Recovery and Reinvestment Act of 2009, Pub. L. No. 111-5, 123 Stat. 115 (February 17, 2009); and Patient Protection and Affordable Care Act of 2010, Pub. L. No. 111-148, 124 Stat. 727 (March 23, 2010).
4. Federal Coordinating Council for Comparative Effectiveness Research, Report to the President and to Congress (Washington, D.C.: Department of Health and Human Services, June 2009).
5. C. D. Mullins et al., "Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials, "Pharmacoeconomics 28, no. 10 (2010): 969-976.
6. B. R. Luce et al., "Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change, "Annals of Internal Medicine 151, no. 3 (2009): 206-209;
7. S. R. Tunis et al., "Practical Clinical Trials: Increasing the Value of Clinical Research for Decision Making in Clinical and Health Policy, "JAMA 290, no. 12 (2003): 1624-1632.
8. R. Faden et al., "Ethics and Informed Consent for Comparative Effectiveness Research with Prospective Electronic Clinical Data, "Medical Care 51, no. 8, Supp. 3 (2013): S53-S57
9. R. R. Faden et al., "Informed Consent, Comparative Effectiveness and Learning Health Care, "New England Journal of Medicine 370, no. 8 (2014): 766-768
10. N. Kass et al., "Addressing Low-Risk Comparative Effectiveness Research in Proposed Changes to US Federal Regulations Governing Research, "JAMA 307, no. 15 (2012): 1589-1590
11. R. Platt et al., "Ethics, Regulation, and Comparative Effectiveness Research: Time for a Change, "JAMA 311, no. 15 (2014): 1497-1498.
12. R. R. Faden and T. L. Beauchamp, A History and Theory of Informed Consent (New York: Oxford University Press, 1986): at 294.
13. N. E. Kass et al., "The Research-Treatment Distinction: A Problemmatic Approach for Determining Which Activities Should Have Ethical Oversight, "Hastings Center Report Special Report 43, no. 1 (2013): S4-S15
14. M. A. Baily, "Harming through Protection?" New England Journal of Medicine 358, no. 8 (2008): 768-769.
15. United States Department of Health, Education, and Welfare, Code of Federal Regulations, Title 45, Part 46.116 (2009).
16. C. H. Braddock et al., "Informed Decision Making in Outpatient Practice: Time to Get Back to Basics, "JAMA 282, no. 24 (1999): 2213-2320
17. C. H. Braddock et al., "How Doctors and Patients Discuss Routine Clinical Decisions, "Journal of General Internal Medicine 12, no. 6 (1997): 339-345.
18. C. G. Rogers et al., "Conventional Consent with Opting In Versus Simplified Consent with Opting Out: An Exploratory Trial for Studies That Do Not Increase Patient Risk, "Journal of Pediatrics 132, no. 4 (1998): 606-611.
19. T. C. Davis et al., "Informed Consent for Clinical Trials: A Comparative Study of Standard Versus Simplified Forms, "Journal of the National Cancer Institute 90, no. 9 (1998): 668-674;
20. G. M. Dresden and M. A. Levitt, "Modifying a Standard Industry Clinical Trial consent Form Improves Patient Information Retention as Part of the Informed Consent Process, "Academic Emergency Medicine 8, no. 3 (2001): 246-252
21. L. Stunkel et al., "Comprehension and Informed Consent: Assessing the Effect of a Short Consent Form, "IRB: Ethics & Human Research 32, no. 4 (2010): 1-9.
22. T. P. Van Staa et al., "Pragmatic Randomized Trials Using Routine Electronic Health Records, "BMJ 344 (2012): e55-e62
23. D. Wendler and C. Grady, "What Should Research Participants Understand to Understand They Are Participants in Research?" Bioethics 22, no. 4 (2008): 203-220
24. L. J. Damschroder et al., "Patients, Privacy and Trust: Patients' Willingness to Allow Researchers to Access Their Medical Records, "Social Science and Medicine 64, no. 1 (2007): 223-235.
25. L. W. Olsen, D. Aisner, and J. M. McGinnis, eds, The Learning Healthcare System: Workshop Summary (Washington, D.C.: National Academies Press, 2007).
26. Patient Centered Outcomes Research Institute, "Large Pragmatic Studies to Evaluate Patient-Centered Outcomes - Winter 2015 Cycle", available at
27. NIH Collaboratory, "The HCS Collaboratory, "available at
28. R. Faden, Stakeholder Views of Streamlined Informed Consent Options for CER Studies, available at
29. Institute of Translational Health Sciences, "RoMP Study Assesses Public Acceptability of Research Policies, "available at